On January 27, 2011, MAPS Clinical Research Associate Berra Yazar-Klosinski, Ph.D., will meet with Kamila Novak, Program Manager of the contract clinical research organization (CRO) Antaea Medical Services, …
Three Australian clinicians are joining the Israeli therapist training program: Stuart Saker, M.D., a psychiatrist with the Australian armed forces; Fiona MacKenzie, a clinical psychologist (and Stuart’s …
From January 23-27, 2001, co-therapists Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., will conduct a therapist training program for the new Israeli clinical team. The meeting will appropriately …
From January 23-27, 2011, MAPS Clinical Investigators Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., conducted a training course for therapists who will be conducting the treatment sessions in MAPS’ …
On January 10, 2011, our clinical team submitted the documents detailing our new protocol for our new Israeli study of MDMA-assisted psychotherapy for PTSD to the Institutional Review Board (IRB) at Beer …
From Oct. 18- 23, MAPS Executive Director Rick Doblin, Ph.D. will be in Israel and Jordan, where he will meet with Clinical Investigator Moshe Kotler, M.D., of our Israeli study, to discuss starting a …
On Oct 14, 2010, Rick Doblin, Ph.D., met in Tel Aviv, Israel, with Moshe Kotler, M.D., Principle Investigator of MAPS’ Israeli MDMA/PTSD study. They discussed the abbreviated clinical report of the …
In our Israeli MDMA/PTSD study, we’ve currently completed a preliminary analysis of the data. All five of the subjects enrolled to date have been treated without any evidence of harm. However, while …
On March 26, 2010, we closed our Israeli MDMA/PTSD study to new subjects in order to provide more training to the therapeutic teams and to our independent rater, to improve our data collection processes, …
On September 30, we submitted our draft protocol, informed consent, and Case Report Forms for our Jordanian MDMA/PTSD research to Principal Investigator Nasser Shuriquie, M.D. and his Jordanian research …
MAPS President Rick Doblin PhD is delighted to share the success of a recent MDMA-assisted psychotherapy session in Israel. Rick was told a remarkable story during a check-in with the therapy team that …
The MAPS-sponsored study in Israel evaluating MDMA-assisted psychotherapy for subjects with war-and terrorism-related posttraumatic stress disorder (PTSD) has full government approval and is now in the …
